WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

EVOGLIPTIN TARTRATE A NEW DRUG OF DPP-4 INHIBITOR: AN OVERVIEW

Kinjal Thakkar*, Khushbu Patel, U. B. Patel and Dr. C. N. Patel

ABSTRACT

DPP4 inhibitors (DPP4i) are a modern class of diabetes medications that retain incretin hormones while increasing postprandial insulin secretion. Gliptins also known as DPP-IV inhibitors is a class of antidiabetic drug. DPP-IV inhibitor like Evogliptin tartrate chemically known as (3R)-4-[(3R)-3-amino- 4-(2,4,5-trifluorophenyl) butanoyl]-3- [(2-methylpropan-2-yl) oxymethyl] piperazin-2-one;(2R,3R)-2,3- dihydroxybutanedioic acid is used as a monotherapy. This article explains about chemistry, pharmacology, safety information and drugdrug interaction of Evogliptin tartrate.

Keywords: Type 2 diabetes, DPP-4 inhibitors, Classification of antidiabetics, Drug interaction.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More